Evaluating the efficacy of rimegepant as a preventive treatment for chronic and episodic migraine: a three-month longitudinal retrospective cohort study - Top-Institutions - MDSpire

Evaluating the efficacy of rimegepant as a preventive treatment for chronic and episodic migraine: a three-month longitudinal retrospective cohort study

  • By

  • Hamza Khan

  • Muhammad Saqib Khan

  • Sheraz Khan

  • Fang Liu

  • Quan Feng

  • Irfan Ahmad

  • Ge Tan

  • June 4, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    The first affiliated hospital of Chongqing Medical University
    The first affiliated hospital of Chongqing Medical University

    Chongqing, Chongqing

    Key Differentiators

    • Neurology

Original Source(s)

Evaluating the efficacy of rimegepant as a preventive treatment for chronic and episodic migraine: a three-month longitudinal retrospective cohort study

  • by Hamza Khan, Muhammad Saqib Khan, Sheraz Khan, Fang Liu, Quan Feng, Irfan Ahmad, Ge Tan

  • June 4, 2026

Related Content

IHS, ACP Differ on Migraine Tx

Experts highlight differences between IHS and ACP recommendations as newer therapies reshape acute and preventive migraine care

Clinical Characteristics and Diagnoses of Inpatients Presenting with Headache: Insights from a Tertiary Care Center in Iran

Atherogenic index of plasma and severe headaches or migraines risk in US adults: a population-based cross-sectional analysis from NHANES 1999–2004